Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kiyoi

Showing results (111-120 of 270) with videos related to

Pageof 27
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitorsHiroshi Ishida, Shoichi Isami, Tsutomu Matsumura, et al.
Oncogene|November 28, 2018
Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activityDaiki Hirano, Fumihiko Hayakawa, Takahiko Yasuda, et al.
British Journal of Haematology|January 26, 2008
Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndromeJinglan Xu, Momoko Suzuki, Yousuke Niwa, et al.
JCI Insight|January 9, 2025
Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophagesTakahiko Sato, Daisuke Sugiyama, Jun Koseki, et al.
Cancer Immunology Research|June 23, 2016
A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug AdministrationReona Sakemura, Seitaro Terakura, Keisuke Watanabe, et al.
International Journal of Hematology|February 27, 2025
Simple and early prediction of severe CAR-T-related adverse events after Axi-cel infusion by initial high feverHiroya Wakabayashi, Seitaro Terakura, Kohei Ishigiwa, et al.
Journal of Thrombosis and Haemostasis : JTH|November 5, 2025
von Willebrand factor-T441N, a novel missense variant in the von Willebrand factor D2 domain, exhibits impaired multimerization and deformed Weibel-Palade bodiesShuichi Okamoto, Shogo Tamura, Atsuo Suzuki, et al.
Pharmacological Research|April 12, 2017
YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphomaYuki Kojima, Fumihiko Hayakawa, Takanobu Morishita, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 23, 2016
Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell ImmunotherapyTatsunori Goto, Tetsuya Nishida, Erina Takagi, et al.
FEBS Letters|June 25, 2019
ZNF384-fusion proteins have high affinity for the transcriptional coactivator EP300 and aberrant transcriptional activitiesHideyuki Yamamoto, Fumihiko Hayakawa, Takahiko Yasuda, et al.
Pageof 27

Showing results (111-120 of 270) with videos related to

Sort By:
Pageof 27
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitorsHiroshi Ishida, Shoichi Isami, Tsutomu Matsumura, et al.
Oncogene|November 28, 2018
Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activityDaiki Hirano, Fumihiko Hayakawa, Takahiko Yasuda, et al.
British Journal of Haematology|January 26, 2008
Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndromeJinglan Xu, Momoko Suzuki, Yousuke Niwa, et al.
JCI Insight|January 9, 2025
Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophagesTakahiko Sato, Daisuke Sugiyama, Jun Koseki, et al.
Cancer Immunology Research|June 23, 2016
A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug AdministrationReona Sakemura, Seitaro Terakura, Keisuke Watanabe, et al.
International Journal of Hematology|February 27, 2025
Simple and early prediction of severe CAR-T-related adverse events after Axi-cel infusion by initial high feverHiroya Wakabayashi, Seitaro Terakura, Kohei Ishigiwa, et al.
Journal of Thrombosis and Haemostasis : JTH|November 5, 2025
von Willebrand factor-T441N, a novel missense variant in the von Willebrand factor D2 domain, exhibits impaired multimerization and deformed Weibel-Palade bodiesShuichi Okamoto, Shogo Tamura, Atsuo Suzuki, et al.
Pharmacological Research|April 12, 2017
YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphomaYuki Kojima, Fumihiko Hayakawa, Takanobu Morishita, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 23, 2016
Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell ImmunotherapyTatsunori Goto, Tetsuya Nishida, Erina Takagi, et al.
FEBS Letters|June 25, 2019
ZNF384-fusion proteins have high affinity for the transcriptional coactivator EP300 and aberrant transcriptional activitiesHideyuki Yamamoto, Fumihiko Hayakawa, Takahiko Yasuda, et al.
Pageof 27